What Is Microvascular Disease? Causes, Types & Diagnosis

Microvascular disease is damage to the body’s smallest blood vessels, the arterioles, capillaries, and venules that deliver oxygen and nutrients directly to tissue. Unlike the blockages in large arteries that most people associate with heart attacks and strokes, microvascular disease operates at a scale too small for standard imaging to see easily, which has historically made it both underdiagnosed and underappreciated. The condition can affect virtually any organ, from the heart and brain to the kidneys and eyes, and its consequences range from chest pain and cognitive decline to organ failure.

What Happens Inside Damaged Small Vessels

Healthy small vessels rely on a thin inner lining of endothelial cells to regulate blood flow. These cells produce nitric oxide, a molecule that relaxes the vessel wall and keeps blood moving smoothly. In microvascular disease, that lining stops working properly. Nitric oxide production drops, the vessels lose their ability to widen on demand, and tissues downstream get less blood than they need. In people with obesity, for instance, inflammatory signals from fat tissue reduce nitric oxide availability, and the enzyme arginase further depletes the raw materials endothelial cells need to make it.¹

Alongside this functional impairment, the vessels themselves can physically disappear. Research on people with high blood pressure has found that capillary density in the skin is significantly lower than in people with normal blood pressure, and this reduction is largely structural, meaning the capillaries are anatomically absent rather than just temporarily shut down.² Follow-up work confirmed that both structural absence and functional nonperfusion contribute to the problem, with people who have hypertension showing impaired recruitment of capillaries even when the body tries to open them up.³ This capillary loss, often called rarefaction, increases the resistance blood encounters as it flows through tissues, which in turn drives blood pressure higher and creates a self-reinforcing cycle.

Coronary Microvascular Disease

Perhaps the most consequential form of microvascular disease affects the heart. Coronary microvascular disease occurs when the small vessels feeding the heart muscle cannot supply enough blood, especially during exertion or stress. The result is chest pain and other symptoms that look a lot like a classic heart attack, yet when doctors perform an angiogram, the large coronary arteries appear clear. This scenario now has a clinical label: ischemia with no obstructive coronary artery disease, or INOCA.⁴

The underlying problem is that the coronary microvasculature cannot adequately supply the heart muscle under stress, and in some cases microvascular spasm restricts flow even at rest.⁵ For years, patients with clear angiograms were sometimes told their symptoms were not cardiac. That view has shifted dramatically. Coronary microvascular dysfunction has also been proposed as a key driver of heart failure with preserved ejection fraction, a form of heart failure where the heart’s pumping strength looks normal on imaging but the organ still cannot meet the body’s demands.⁶ When researchers measured coronary flow and microvascular resistance directly in these patients, roughly three-quarters showed abnormalities, compared with less than a third of healthy controls.⁷

Cerebral Small Vessel Disease

The brain’s tiny perforating arteries are especially vulnerable. When they deteriorate, the condition is known as cerebral small vessel disease, and it accounts for a large share of strokes and an even larger share of vascular dementia. Research has identified a cascade of problems stemming from damaged brain microvessels: the blood-brain barrier breaks down, vessels stiffen, blood flow and fluid drainage become dysfunctional, and the surrounding white matter deteriorates through ischemia, inflammation, and myelin damage, eventually leading to neurodegeneration.⁸

On brain MRI, the hallmarks of small vessel disease include bright patches in the white matter called white matter hyperintensities and small cavities called lacunes. A study tracking where new lacunes appeared found that over ninety percent of them developed at the edge of an existing white matter hyperintensity, suggesting the two types of damage share a common mechanism and that the border zone of an existing lesion is particularly fragile.⁹ Post-mortem research in people with hypertension has confirmed that endothelial disruption, blood-brain barrier damage, and neurovascular inflammation are already present in normal-appearing white matter, not just in the visible lesions, hinting that the disease process starts well before it shows up on a scan.¹⁰

Vascular cognitive impairment frequently coexists with Alzheimer’s pathology, and mounting evidence suggests that neurovascular unit dysfunction, including chronic low blood flow and blood-brain barrier disruption, is a central driver of cognitive decline across multiple disease types.¹¹ In Alzheimer’s disease specifically, impaired clearance of amyloid-beta from the brain by the neurovascular unit can lead to its buildup on blood vessel walls, a condition known as cerebral amyloid angiopathy, which further damages vessels and can cause microbleeds.¹²

Diabetic Microvascular Complications

Diabetes is one of the most common drivers of microvascular disease because chronically high blood sugar directly damages small vessels throughout the body. Glucose reacts with proteins over time to form compounds called advanced glycation end products, which create irreversible cross-links in structural proteins like collagen.¹³ These altered proteins make vessel walls stiffer and trigger inflammation, contributing to the classic trio of diabetic microvascular complications: damage to the retina (retinopathy), to the kidneys (nephropathy), and to peripheral nerves (neuropathy).¹⁴

What makes the diabetic form distinctive is the sheer range of organs affected simultaneously. A person with poorly controlled type 2 diabetes might develop blurred vision from retinal vessel leakage, rising creatinine from kidney damage, and numbness in the feet from nerve damage, all driven by the same underlying microvascular injury. Tight blood sugar control remains the most effective way to slow this progression, though damage already done to the microvascular beds is generally not reversible.

Autoimmune and Systemic Forms

Microvascular disease also appears in autoimmune conditions, most prominently in systemic sclerosis, where Raynaud’s phenomenon, the sudden whitening and pain in fingers triggered by cold, is a hallmark of underlying microangiopathy. In systemic sclerosis, this microvascular damage can extend beyond the fingers to affect the heart.¹⁵ The tiny vessels progressively narrow, and the body’s attempts to repair them often result in fibrosis rather than functional recovery. Rheumatologists frequently use nailfold capillaroscopy, a simple office-based technique, to visualize the capillaries at the base of the fingernail, where early microvascular damage in autoimmune disease can be spotted before organ involvement becomes apparent.¹⁶

Why Women Are Disproportionately Affected

Coronary microvascular disease has a notable sex disparity. Chest pain with no obstructive coronary blockages occurs more frequently in women than in men, and microvascular angina due to coronary microvascular disease is more common in women and carries increased risk of future cardiovascular events.¹⁷ The majority of coronary microvascular disease patients are postmenopausal women, which points to a protective role for estrogen that is lost after menopause.¹⁸

This has real clinical consequences. Women presenting with chest pain are more likely to have their angiogram come back “clean” and be reassured that nothing is wrong, when in fact their small vessels are failing. The INOCA framework has helped change this, but awareness still lags. If you are a woman with recurrent chest pain and normal-looking coronary arteries, asking your cardiologist specifically about microvascular testing is reasonable.

Post-Viral Microvascular Damage

COVID-19 drew sharp attention to microvascular disease in a new context. Autopsies of patients who died from severe COVID-19 revealed widespread endothelial injury in the lungs, with the virus found inside endothelial cells and the cell membranes disrupted. Alveolar capillary microthrombi, tiny clots in the lung’s smallest vessels, were about nine times more common in COVID-19 lungs than in lungs from patients who died of influenza.¹⁹ This was not just a respiratory infection; it was a vascular one.

Long COVID has reinforced the connection. Many persistent symptoms, including fatigue, brain fog, and exercise intolerance, have been linked to ongoing endothelial dysfunction and a state sometimes described as thrombotic endothelialitis.²⁰ This is an area where the research is still evolving, but the principle that viral infections can trigger lasting microvascular injury is now firmly established.

How Microvascular Disease Is Diagnosed

One of the biggest challenges with microvascular disease is that standard tests often miss it. A routine angiogram checks the large coronary arteries; if those look fine, the result is technically “normal,” even though the microvasculature may be severely impaired. Detecting the problem requires more specialized tools.

Invasive Coronary Testing

For the heart, the most specific invasive test uses a thin pressure-and-temperature-sensing wire threaded into a coronary artery during catheterization. The index of microcirculatory resistance measures the smallest achievable resistance in the microvascular bed after a drug is used to dilate the vessels maximally. Compared with older Doppler-based coronary flow reserve measurements, which reflect the entire coronary circulation and have poor reproducibility, this newer method is more reproducible, has clearer normal values, and is specific to the microvasculature itself.²¹

Non-Invasive Imaging

For patients who do not need catheterization, positron emission tomography (PET) is considered the gold standard for non-invasive assessment of microvascular function. It quantifies blood flow through the heart muscle at rest and under stress, making it possible to detect reduced flow reserve even when the large arteries are clear. Cardiac MRI and cardiac CT have also emerged as options for evaluating the microcirculation.²²

Bedside Techniques

Outside the heart, nailfold videocapillaroscopy provides a simple, non-invasive window into the peripheral microcirculation. A clinician places a small magnifying camera on the skin at the base of the fingernail and examines the capillary loops directly.²³ The technique is well established in rheumatology for tracking autoimmune microangiopathy and is increasingly being explored for cardiovascular conditions. It takes only a few minutes, costs very little, and can reveal enlarged, distorted, or absent capillaries that indicate microvascular damage.²⁴

Blood Biomarkers

Researchers are also pursuing blood-based markers of microvascular injury. Endothelial microparticles, tiny membrane fragments shed by damaged or activated endothelial cells, are elevated in various cardiovascular diseases and are being studied as a potential biomarker of vascular damage.²⁵ These microparticles reflect the degree of endothelial cell damage and may help gauge disease severity.²⁶ Other candidate markers include von Willebrand factor, asymmetric dimethylarginine, and E-selectin, though none has yet reached routine clinical use.²⁷ The development of circulating biomarkers of vascular aging, including components of the senescence-associated secretory phenotype and endothelial-derived extracellular vesicles, could eventually enable early detection in people at high risk for cognitive decline.²⁸

Treatment Options

Because microvascular disease is driven largely by endothelial dysfunction and inflammation, treatment overlaps with, but is not identical to, treatment for large-vessel atherosclerosis. A meta-analysis of drug trials in patients without significant blockages in their large coronary arteries found that ACE inhibitors, angiotensin receptor blockers, and statins all improved coronary flow reserve.²⁹ These drugs address some of the upstream drivers: ACE inhibitors and ARBs counter the excessive vasoconstriction mediated by angiotensin II, while statins have anti-inflammatory effects beyond their cholesterol-lowering role. In women with a history of preeclampsia, who are at elevated risk for persistent microvascular dysfunction, losartan improved microvascular endothelial function through nitric oxide-dependent pathways.³⁰

For coronary microvascular angina specifically, patients often take combinations of beta-blockers, calcium-channel blockers, and other anti-ischemic medications. Ranolazine, a drug that works by a different mechanism than standard anti-anginals, has been studied in randomized trials for patients with chest pain and no obstructive coronary artery disease, typically added on top of existing therapy.³¹ The treatment landscape is still evolving, and no single drug has emerged as a definitive fix. Many patients need to try several combinations before finding one that controls symptoms.

Exercise and the Microvasculature

Among lifestyle interventions, aerobic exercise has the strongest evidence for directly improving microvascular function. In a study of older adults, an aerobic exercise program increased peak blood flow to the muscles by about 39% and improved the microvascular oxygen response by about a third, while a non-exercising control group showed no change.³² Exercise training improved microvascular function even in burn injury survivors, a group with significant baseline vascular damage, with improvements in peak vascular conductance and the vasodilatory response after training.³³

Animal research adds an encouraging finding: exercise started late in life reversed age-related declines in both coronary microvascular function and diastolic heart function, largely by restoring endothelial function in the small coronary vessels.³⁴ The takeaway here is that microvascular damage is not a one-way street. Regular aerobic activity appears to partially restore the endothelial function that underlies almost every form of microvascular disease.

Inherited Small Vessel Disease

Not all microvascular disease is acquired. CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is the most common inherited cerebral small vessel disease. It is caused by mutations in the NOTCH3 gene and leads to lacunar strokes and vascular dementia, often beginning in mid-adulthood. Individuals with the disease show variability in when symptoms appear and how quickly they progress, and differences in the specific NOTCH3 mutation explain only part of that variability.³⁵ Other genetic factors, lifestyle, and vascular risk factors all influence the course. CADASIL is rare, but it illustrates that microvascular fragility can be hardwired, not just the result of diabetes, hypertension, or aging. If you have a family history of early strokes or dementia with a pattern that skips large-vessel blockages, genetic testing for CADASIL and related conditions may be worth discussing with a neurologist.

Beyond monogenic diseases like CADASIL, there is growing interest in whether accelerated microvascular aging, involving cellular senescence and the inflammatory signals aging cells release, contributes to vascular cognitive impairment more broadly. Senescent endothelial cells in the brain’s microvessels promote blood flow dysregulation, blood-brain barrier disruption, and microbleeds, and researchers are working to develop circulating biomarkers that could flag this process early in at-risk individuals.²⁸